Several Medicare Administrative Contractors (MACs) have local coverage determinations (LCDs), local coverage articles (LCAs), or published bulletins specifying the HCPCS code required for ophthalmic use of bevacizumab, and these can be reviewed at aao.org/lcds
Intravenous therapy is not new
If youre enjoying these episodes, let us know
The BNF recently (2019) changed its guidance for the frequency of injections of hydroxocobalamin: Every 2 months in patients who have neurological symptoms Every 2 or 3 months when there are no neurological symptoms
Its important to know the differences to treat patients well
Any significant deviation from the initial appearancesuch as darkening, fading, cloudiness, or particle formationshould prompt immediate contact with the compounding pharmacy before administration